Sujata Agarwal, Surender Mittal, G. N. Saxena


Background: Microalbuminuria is an established marker of kidney as well as cardiovascular damage in diabetics but its association in hypertension is not very well known.  As hypertension is a major cause of morbidity and mortality all over world, especially in India. Present study was undertaken to correlate Microalbuminuria with systolic and diastolic hypertension.


Methodology: Thirty patients of hypertension coming to OPD/Wards of MGUMST, Jaipur who fulfilled the inclusion criteria were recruited. They were subjected to detailed history, clinical examination & diagnostic tests. Data analysis was done using SPSS software.


Results: Microalbuminuria has a stronger association with diastolic blood pressure (BP). As 100% patients with stage 2 diastolic BP had microalbuminuria ( p <0.05); compared with 84.6%  in Stage II systolic hypertension (p value > 0.05).


Conclusion: In hypertension there is a higher prevalence of microalbuminuria in patients with raised diastolic BP compared to systolic BP. We recommend screening for Microalbuminuria in all hypertensive patients as it is an important prognostic marker for cardiovascular as well as renal morbidity & mortaity. This will also guide us towards selection of appropriate drugs and formulating preventive strategy.


hypertension, diastolic blood pressure, systolic blood pressure, microalbuminuria,

Full Text:



Harrison”s principle of internal medicine 19th edition ;ch 298; page 1611

He J, Whelton P. Epidemiology and Prevention of Hypertension. Medical Clinics of North America. 1997; 81(5):1077-97.

Whelton PK. Epidemiology of Hypertension. Lancet. 1994; 344:101-06.

Volpe M Int J Clin pract. 2008. Microalbuminuria screening in patients with hypertension: recommendation for clinical practice.

Mule G, et al. Adv Exp Med Biol. 2017. Subclinical kidney damage in hypertensive patients. A renal window opened on the cardiovascular system. Focus on Microalbuminuria .

Pulse pressure and isolated systolic hypertension: Association with Microalbuminuria MassimoCirilloDavide;StellatoMartinoLaurenzi;WalterPanarelli;AlbertoZanchettiNatale G.De Santo

Indian J Nephrol. 2008 Jul; 18(3): 112–117. doi: 10.4103/0971-4065.43690 PMCID: PMC2813138 M. Afkhami-Ardekani, M. Modarresi, and E. Amirchaghmaghi ;Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients;

Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India ;;A Varghese, R Deepa, M Rema, V Mohan;; March 9, 2018 - Published by N Am J Med Sci.

2012 Aug; 4(8): 331–335. doi: 10.4103/1947-2714.99501 PMCID: PMC3421910;Prevalence and Association of Microalbuminuria in Essential Hypertensive PatientsBibek Poudel, Binod Kumar Yadav,1 Ashwini Kumar Nepal,2 Bharat Jha,1 and Kanak Bahadur Raut3

Ezzati M, Lopez AD, Rodgers A, Hoorn VS, Murray CJ. Selected major risk factors J global and regional burden of disease. Lancet.2002; 360:1347–60.

Sarnak J, Levey S, Schoolwerth C. Kidney disease as a risk factor for development of cardiovascular disease : A statement from the

American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology,

and Epidemiology and Prevention. Circulation .2003; 108:254.

Microalbuminuria in Essential Hypertension Reduction by Different Antihypertensive Drugs ;Christiane M.;Erley, Uwe Haefele, Nils Heyne,;Norbert Braun, andTeut Risler


  • There are currently no refbacks.